Amlodipine + Telmisartan

Welcome to Dwaey, specifically on Amlodipine + Telmisartan page.
This medicine contains important and useful components, as it consists of
Amlodipine + Telmisartan is available in the market in concentration.

Generic Name of Amlodipine + Telmisartan - Learn More

Amlodipine + Telmisartan

Amlodipine + Telmisartan Precaution - What You Need to Know

The combination of amlodipine and telmisartan is commonly used for the treatment of hypertension and offers benefits through dual mechanisms of action. However, it is important to consider certain precautions before initiating therapy:

- Renal Impairment: Both amlodipine and telmisartan can impact kidney function. Telmisartan, an angiotensin II receptor blocker (ARB), can cause hyperkalemia and decrease renal function, especially in patients with pre-existing renal impairment. Kidney function should be monitored regularly, particularly in those with mild to moderate renal impairment. Amlodipine generally does not require dosage adjustment in renal disease, but caution is advised.
- Hypotension: Amlodipine, a calcium channel blocker, can lead to vasodilation and potentially cause a significant drop in blood pressure, especially in volume-depleted or elderly patients. It is essential to monitor blood pressure closely after the initial dose to avoid hypotension.
- Pregnancy and Breastfeeding: This combination is contraindicated during pregnancy, particularly in the second and third trimesters, as ARBs like telmisartan can harm the fetus, leading to fetal renal damage, hypotension, and even death. Amlodipine is categorized as a pregnancy Category C drug, meaning it should be used with caution in pregnant women. Both drugs are excreted in breast milk, so their use should be avoided during breastfeeding unless absolutely necessary.
- Angioedema: ARBs, including telmisartan, have been associated with rare but serious side effects like angioedema (swelling of the face, tongue, or throat). Immediate medical attention is required if such symptoms occur.

Amlodipine + Telmisartan Indication - Uses and Benefits

The primary indication for the combination of amlodipine and telmisartan is the treatment of essential hypertension. This combination is beneficial in lowering blood pressure through two complementary mechanisms:

- Amlodipine: As a calcium channel blocker, amlodipine works by inhibiting calcium ion entry into vascular smooth muscle cells, causing vasodilation, which helps to reduce peripheral resistance and lower blood pressure.
- Telmisartan: This ARB works by blocking the effects of angiotensin II, a hormone that causes blood vessels to constrict. By inhibiting its action, telmisartan promotes vasodilation and reduces blood pressure.

This combination therapy is effective in patients whose blood pressure is not adequately controlled with either amlodipine or telmisartan alone. It is especially useful in patients who have concomitant conditions such as heart failure or chronic kidney disease, as telmisartan offers kidney protection, and amlodipine improves blood flow to the heart.

Off-label uses include potential benefit in preventing stroke and in patients with diabetes at risk for kidney damage. However, it is essential to follow evidence-based guidelines and monitor patients for side effects and efficacy.

Amlodipine + Telmisartan Contraindications - Important Warnings

The combination of amlodipine and telmisartan is contraindicated in several conditions:

- Hypersensitivity: Patients with a known hypersensitivity to either amlodipine, telmisartan, or any component of the formulation should not use this combination.
- Pregnancy: Both amlodipine and telmisartan should be avoided during pregnancy. Telmisartan is particularly contraindicated during the second and third trimesters due to the risk of fetal harm (renal dysfunction, hypotension, and death).
- Severe Renal Impairment: Patients with severe renal impairment (creatinine clearance < 30 mL/min) should avoid this combination. Telmisartan can exacerbate renal dysfunction in these patients.
- Bilateral Renal Artery Stenosis: Both amlodipine and telmisartan can reduce renal perfusion, making this combination unsafe in patients with bilateral renal artery stenosis, as it may lead to acute renal failure.
- Severe Hepatic Impairment: Caution should be used in patients with severe liver disease since amlodipine and telmisartan can accumulate in the body in such cases.

Amlodipine + Telmisartan Side Effects - What to Expect

The side effects of amlodipine and telmisartan are generally mild but can include the following:

- Common Side Effects:
- Amlodipine: Swelling of the ankles or feet, headache, dizziness, palpitations, and fatigue are commonly reported. These effects are often related to the vasodilation caused by amlodipine.
- Telmisartan: Dizziness, headache, and fatigue are typical side effects. It can also cause elevated potassium levels (hyperkalemia) and lower kidney function in some patients.
- Combination Therapy: Hypotension, particularly after the first dose, can occur when starting the combination therapy, especially in volume-depleted or elderly patients.

- Serious but Rare Side Effects:
- Amlodipine: Gingival hyperplasia (gum overgrowth) and liver enzyme abnormalities, though rare, can occur.
- Telmisartan: Severe allergic reactions like angioedema (swelling of the throat, tongue, or lips) are rare but require immediate medical attention.
- Electrolyte Imbalance: Both drugs can contribute to electrolyte imbalances, such as hyperkalemia or hyponatremia, so careful monitoring is essential, particularly for patients with renal issues.

Patients should seek immediate medical attention if they experience any signs of severe allergic reactions, chest pain, or unusually severe dizziness.

Amlodipine + Telmisartan Pregnancy Category ID - Safety Information

17

Amlodipine + Telmisartan Mode of Action - How It Works

The combination of amlodipine and telmisartan works synergistically to reduce blood pressure:

- Amlodipine: As a calcium channel blocker, amlodipine inhibits calcium influx into smooth muscle cells in the arteries, leading to their relaxation (vasodilation). This reduces systemic vascular resistance and lowers blood pressure. Amlodipine also improves myocardial oxygen supply, reducing angina.
- Telmisartan: Telmisartan is an angiotensin II receptor blocker (ARB), which blocks the action of angiotensin II, a hormone that constricts blood vessels and increases blood pressure. By inhibiting angiotensin II receptors, telmisartan promotes vasodilation, reduces aldosterone secretion (leading to reduced fluid retention), and helps lower blood pressure.

This dual approach helps to effectively lower blood pressure through both vasodilation and inhibition of the renin-angiotensin-aldosterone system (RAAS), a key pathway in blood pressure regulation.

Amlodipine + Telmisartan Drug Interactions - What to Avoid

Several drug-drug interactions are important to consider when using amlodipine and telmisartan:

- Other Antihypertensive Agents: Concomitant use with other antihypertensive agents (such as diuretics or beta-blockers) may cause an additive effect, leading to an increased risk of hypotension. Blood pressure should be closely monitored, particularly after initiating or adjusting doses.
- Potassium-Sparing Diuretics or Potassium Supplements: Telmisartan can increase potassium levels, so the combination with potassium-sparing diuretics (e.g., spironolactone) or potassium supplements should be avoided unless carefully monitored to prevent hyperkalemia.
- NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): The concurrent use of NSAIDs with ARBs like telmisartan can impair renal function and reduce the antihypertensive effect of telmisartan. NSAIDs can also lead to fluid retention, further complicating blood pressure management.
- Lithium: Combining lithium with telmisartan and amlodipine may increase the risk of lithium toxicity. Lithium levels should be closely monitored if used concomitantly.
- Cytochrome P450 Inhibitors: Amlodipine is metabolized by the CYP3A4 enzyme. Drugs that inhibit CYP3A4 (e.g., ketoconazole, grapefruit juice) may increase amlodipine levels, necessitating dose adjustment. Conversely, CYP3A4 inducers (e.g., rifampin) can reduce amlodipine levels.

Amlodipine + Telmisartan Pregnancy Category Note - Key Information

Pregnancy Category: C (1st trimester); D (2nd & 3rd trimesters)

Amlodipine + Telmisartan Adult Dose - Recommended Dosage

The typical starting dose of amlodipine is 5 mg once daily, which can be increased to a maximum of 10 mg daily depending on the patient’s response. The typical starting dose of telmisartan is 40 mg once daily, with the possibility of increasing the dose to 80 mg or 160 mg daily if necessary to achieve adequate blood pressure control.

For combination therapy, fixed-dose formulations are available, typically amlodipine 5 mg + telmisartan 40 mg or amlodipine 5 mg + telmisartan 80 mg. Doses should be adjusted based on blood pressure readings and patient tolerance.

Amlodipine + Telmisartan Child Dose - Dosage for Children

The combination of amlodipine and telmisartan is not generally recommended for pediatric patients under the age of 18 due to limited data on safety and efficacy in this population. Amlodipine may be used in children aged 6 years and older for hypertension, starting at 2.5 mg once daily, while telmisartan has been used off-label in children with hypertension, but dosage must be adjusted based on the child’s weight and renal function.

Both drugs should only be used in children under careful medical supervision and with appropriate monitoring to prevent adverse effects like electrolyte imbalances and hypotension.

Amlodipine + Telmisartan Renal Dose - Dosage for Kidney Conditions

In patients with mild to moderate renal impairment (creatinine clearance between 30 and 60 mL/min), the dose of amlodipine does not need adjustment. However, telmisartan should be used cautiously, and its dose may need to be reduced to avoid further deterioration of renal function.

In patients with severe renal impairment (creatinine clearance < 30 mL/min), the combination of amlodipine and telmisartan is generally not recommended due to the potential for further kidney function decline and adverse effects. Regular monitoring of renal function is necessary, especially in patients with pre-existing kidney disease.